[1] EKKER M S，BOOT E M，SINGHAL A B，et

al. Epidemiology，aetiology，and management of

ischaemic stroke in young adults[J]. Lancet Neurol，

2018，17（9）：790-801.

[2] SCHIEVINK W I. Spontaneous dissection of the

carotid and vertebral arteries[J]. N Engl J Med，2001，

344（12）：898-906.

[3] SCHWARTZ N E，VERTINSKY A T，HIRSCH K

G，et al. Clinical and radiographic natural history of

cervical artery dissections[J]. J Stroke Cerebrovasc

Dis，2009，18（6）：416-423.

[4] GUILLON B，TZOURIO C，BIOUSSE V，et al.

Arterial wall properties in carotid artery dissection：

an ultrasound study[J]. Neurology，2000，55（5）：

663-666.

[5] SILBERT P L，MOKRI B，SCHIEVINK W I.

Headache and neck pain in spontaneous internal

carotid and vertebral artery dissections[J]. Neurology，

1995，45（8）：1517-1522.

[6] CRUM B，MOKRI B，FULGHAM J. Spinal

manifestations of vertebral artery dissection[J].

Neurology，2000，55（2）：304-306.

[7] SAW A E，MCINTOSH A S，KOUNTOURIS A.

Vertebral artery dissection in sport：expert opinion

of mechanisms and risk-reduction strategies[J/OL]. J

Clin Neurosci，2019，68：28-32[2020-06-15].

https：//doi.org/10.1016/j.jocn.2019.07.016.

[8] URASYANANDANA K，SONGSANG D，

AURBOONYAWAT T，et al. Treatment outcomes

in cerebral artery dissection and literature review[J].

Interv Neuroradiol，2018，24（3）：254-262.

[9] GOTTESMAN R F，SHARMA P，ROBINSON K

A，et al. Imaging characteristics of symptomatic

vertebral artery dissection：a systematic review[J].

Neurologist，2012，18（5）：255-260.

[10] 中华医学会神经病学分会，中华医学会神经病学

分会脑血管病学组. 中国颈部动脉夹层诊治指南

2015[J]. 中华神经科杂志，2015，48（8）：644-651.

[11] HANELINE M T，ROSNER A L. The etiology of

cervical artery dissection[J]. J Chiropr Med，2007，6

（3）：110-120.

[12] PEZZINI A，DEL Z E，PADOVANI A.

Hyperhomocysteinemia：a potential risk factor for

cervical artery dissection following chiropractic

manipulation of the cervical spine[J]. J Neurol，2002，

249（10）：1401-1403

[13] OLTEANU H，BANERJEE R. Human methionine

synthase reductase，a soluble P-450 reductaselike

dual flavoprotein，is sufficient for NADPHdependent

methionine synthase activation[J]. J Biol

Chem，2001，276（38）：35558-35563.

[14] BROWN C A，MCKINNEY K Q，KAUFMAN J

S，et al. A common polymorphism in methionine

synthase reductase increases risk of premature

coronary artery disease[J]. J Cardiovasc Risk，2000，

7（3）：197-200.

[15] KIM Y J，LEE J K，AHN S H，et al.

Nonatheroscleotic isolated middle cerebral artery

disease may be early manifestation of moyamoya

disease[J]. Stroke，2016，47（9）：2229-2235.

[16] FROSST P，BLOM H J，MILOS R，et al. A

candidate genetic risk factor for vascular disease：a common mutation in methylenetetrahydrofolate

reductase[J]. Nat Genet，1995，10（1）：111-113.

[17] WILCKEN B，BAMFORTH F，LI Z，et al.

Geographical and ethnic variation of the 677C>T

allele of 5，10 methylenetetrahydrofolate reductase

（MTHFR）：findings from over 7000 newborns from

16 areas world wide[J]. J Med Genet，2003，40（8）：

619-625.

[18] KLOSS M，WIEST T，HYRENBACH S，et al.

MTHFR 677TT genotype increases the risk for

cervical artery dissections[J]. J Neurol Neurosurg

Psychiatry，2006，77（8）：951-952.

[19] WU P P，TANG R N，AN L. A meta-analysis of

MTRR A66G polymorphism and colorectal cancer

susceptibility[J]. J BUON，2015，20（3）：918-922.

[20] GAUGHAN D J，KLUIJTMANS L A，BARBAUX

S，et al. The methionine synthase reductase（MTRR）

A66G polymorphism is a novel genetic determinant

of plasma homocysteine concentrations[J].

Atherosclerosis，2001，157（2）：451-456.

[21] HOBBS C A，SHERMAN S L，YI P，et al.

Polymorphisms in genes involved in folate

metabolism as maternal risk factors for Down

syndrome[J]. Am J Hum Genet，2000，67（3）：623-

630.